| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| Additional-Strength-..> | 2018-07-03 15:49 | 168K | ||
| BCS-Biowaiver-Form-N..> | 2018-07-03 15:49 | 173K | ||
| BTIF-NAFDAC224032641..> | 2018-07-03 15:49 | 67K | ||
| Letter-of-Access-for..> | 2018-07-07 08:47 | 7.6K | ||
| Letter-of-Access-for..> | 2018-07-07 08:45 | 7.8K | ||
| NAFDAC-QIS-Template2..> | 2018-07-03 15:50 | 290K | ||
| NAFDAC-QOS-PD26379.docx | 2018-07-03 15:50 | 279K | ||
| Patient-Information-..> | 2018-07-07 08:34 | 39K | ||
| Screening-Checklist-..> | 2020-10-19 21:10 | 154K | ||
| Summary-of-Product-C..> | 2018-07-07 08:38 | 41K | ||
| Vaccine-Variation-Ap..> | 2019-06-11 13:06 | 38K | ||
| Variation-Applicatio..> | 2019-05-04 22:13 | 93K | ||
| Variation-Applicatio..> | 2019-05-04 22:16 | 90K | ||